Biodel to Report Results of VIAject(TM) Pivotal Phase III Clinical Trials at EASD Conference.
Business Wire › September 03, 2008
Linked as:
Extract
Biodel to Report Results of VIAject(TM) Pivotal Phase III Clinical Trials at EASD Conference.
Webcast/Conference Call Scheduled for 8:00 am EDT on Tuesday, September 9, 2008
DANBURY, Conn. -- Biodel Inc. (Nasdaq: BIOD) announced today that it will report results of its two pivotal Phase III clinical trials of VIAject[TM] in patients with Type 1 and Type 2 diabetes next week at the 44th ...See the full content of this document
Sponsored links
